Chromogranin A, a significant prognostic factor in small cell lung cancer
Open accessThe DOI matches its Crossref record.
Abstract
Chromogranin A (CgA) is a protein present in neuroendocrine vesicles. Small cell lung cancer (SCLC) is considered a neuroendocrine tumour. It is possible to demonstrate CgA expression in SCLC by immunohistochemical methods. Since CgA is released to the circulation it might also work as a clinical tumour marker. We used a newly developed two-site enzyme-linked immunosorbent assay for CgA in plasma from 150 newly diagnosed patients with SCLC. Follow-up was for a minimum of 5 years. Thirty-seven per cent of the patients had elevated pretreatment values and the values were significantly related to stage of disease. Multivariable analysis by Cox's proportional hazard model including nine known prognostic factors disclosed performance status as the most influential prognostic factor followed by stage of disease, CgA and LDH. A simple prognostic index (PI) could be established based on these four pretreatment features. In this way the patients could be separated into three groups with significant different prognosis. The median survival and 95% confidence intervals for the three groups were as follows: 424 days (311-537), 360 days (261-459) and 174 days (105-243).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The diagnosis and medical management of advanced neuroendocrine tumors.
Kaltsas, G. A., Besser, G. M., & Grossman, A. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0014 · Cited by 674
Biological variation of neuroendocrine tumor markers chromogranin A and neuron-specific enolase
Braga, F., Ferraro, S., Mozzi, R., Dolci, A., & Panteghini, M. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.09.005 · Cited by 49
Børglum, T., Rehfeld, J. F., Drivsholm, L. B., & Hilsted, L. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.076158 · Cited by 42
Self-citation
Metadata
- Authors
- Drivsholm, L., Paloheimo, L. I., & Østerlind, K.
- Venue
- British Journal of Cancer
- Published
- 1999-09-24
- Volume
- 81
- Issue
- 4
- Pages
- 667-671
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2026317796
- Cited by
- 40
- References
- 0
- FWCI
- 0.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chromogranin A, a significant prognostic factor in small cell lung cancer. https://app.cochat.ai/papers/10.1038/sj.bjc.6690745
- The paper
- Drivsholm, L., Paloheimo, L. I., & Østerlind, K. (1999). Chromogranin A, a significant prognostic factor in small cell lung cancer. British Journal of Cancer. https://doi.org/10.1038/sj.bjc.6690745
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.